Roles of commensal microbiota in pancreas homeostasis and pancreatic pathologies

Journal of Diabetes Research

Volumn 2015, Issue , 2015, Pages

  Leal Lopes, Camila ^a   Velloso, Fernando J ^a   Campopiano, Julia C ^a   Sogayar, Mari C ^a   Correa, Ricardo G ^b  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

^b BURNHAM INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACINAR CELL; ACUTE PANCREATITIS; ARTICLE; AUTOIMMUNE PANCREATITIS; BACTEROIDES; BIFIDOBACTERIUM; BIFIDOBACTERIUM ADOLESCENTIS; CLOSTRIDIUM; CYTOKINE RESPONSE; DIABETES MELLITUS; DYSBIOSIS; EXOCRINE SECRETION; FIRMICUTES; FUNCTIONAL ANATOMY; HELICOBACTER INFECTION; HELICOBACTER PYLORI; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; INTESTINE FLORA; KLEBSIELLA; LACTOBACILLUS; MICROBIOME; MICROFLORA; NEUROENDOCRINE TUMOR; NEXT GENERATION SEQUENCING; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; PANCREAS ADENOCARCINOMA; PANCREAS CANCER; PANCREAS DISEASE; PANCREAS FUNCTION; PANCREAS INJURY; PANCREAS ISLET CELL TUMOR; PANCREATITIS; PATHOGENESIS; PREVOTELLA; PRIORITY JOURNAL; STEADY STATE; TANNERELLA; VEILLONELLA; ANIMAL; DISEASE COURSE; HOMEOSTASIS; INFLAMMATION; MICROBIOLOGY; PANCREAS; PANCREAS TUMOR; PATIENT SAFETY; PHYSIOLOGY;

ANIMALS; DIABETES COMPLICATIONS; DIABETES MELLITUS; DISEASE PROGRESSION; GASTROINTESTINAL MICROBIOME; HOMEOSTASIS; HUMANS; INFLAMMATION; PANCREAS; PANCREATIC NEOPLASMS; PANCREATITIS; PATIENT SAFETY;

EID: 84939609921     PISSN: 23146745     EISSN: 23146753     Source Type: Journal    
DOI: 10.1155/2015/284680     Document Type: Article

References (244)

1. P. J. Turnbaugh, R. E. Ley, M. Hamady, C. M. Fraser-Liggett, R. Knight, and J. I. Gordon, "The human microbiome project, " Nature, vol. 449, no. 7164, pp. 804-810, 2007.
2. J. Peterson, S. Garges, M. Giovanni et al., "The NIH human microbiome project, " Genome Research, vol. 19, no. 12, pp. 2317-2323, 2009.
3. M. J. Blaser, "The microbiome revolution, " Journal of Clinical Investigation, vol. 124, no. 10, pp. 4162-4165, 2014.
4. S. G. Tringe, C. von Mering, A. Kobayashi et al., "Comparative metagenomics of microbial communities, " Science, vol. 308, no. 5721, pp. 554-557, 2005.
5. F. Guarner, "Enteric flora in health and disease, " Digestion, vol. 73, supplement 1, pp. 5-12, 2006.
6. Y. Belkaid and T.W. Hand, "Role of the microbiota in immunity and inflammation, " Cell, vol. 157, no. 1, pp. 121-141, 2014.
7. D. C. Savage, "Microbial ecology of the gastrointestinal tract, " Annual Review of Microbiology, vol. 31, pp. 107-133, 1977.
8. W. B. Whitman, D. C. Coleman, and W. J. Wiebe, "Prokaryotes: the unseen majority, " Proceedings of the National Academy of Sciences of the United States of America, vol. 95, no. 12, pp. 6578-6583, 1998.
9. M. R. Redinbo, "The microbiota, chemical symbiosis, and human disease, " Journal of Molecular Biology, vol. 426, no. 23, pp. 3877-3891, 2014.
10. S. Sirisinha, "Insight into the mechanisms regulating immune homeostasis in health and disease, " Asian Pacific Journal of Allergy and Immunology, vol. 29, no. 1, pp. 1-14, 2011.
11. A. Ochi, C. S. Graffeo, C. P. Zambirinis et al., "Toll-like receptor 7 regulates pancreatic carcinogenesis in mice and humans, " Journal of Clinical Investigation, vol. 122, no. 11, pp. 4118-4129, 2012.
12. A. Ochi, A.H. Nguyen, A. S. Bedrosian et al., "MyD88 inhibition amplifies dendritic cell capacity to promote pancreatic carcinogenesis viaTh2cells, "The Journal of ExperimentalMedicine, vol. 209, no. 9, pp. 1671-1687, 2012.
13. R. Sharif, R. Dawra, K. Wasiluk et al., "Impact of toll-like receptor 4 on the severity of acute pancreatitis and pancreatitisassociated lung injury in mice, " Gut, vol. 58, no. 6, pp. 813-819, 2009.
14. R. Hoque, M. Sohail, A. Malik et al., "TLR9 and the NLRP3 inflammasomelink acinar cell death with inflammation in acute pancreatitis, " Gastroenterology, vol. 141, no. 1, pp. 358-369, 2011.
15. Y. Tsuji, T. Watanabe, M. Kudo, H. Arai, W. Strober, and T. Chiba, "Sensing of commensal organisms by the intracellular sensor nod1 mediates experimental pancreatitis, " Immunity, vol. 37, no. 2, pp. 326-338, 2012.
16. C. P. Zambirinis, S. Pushalkar, D. Saxena, and G. Miller, "Pancreatic cancer, inflammation, and microbiome, " Cancer Journal, vol. 20, no. 3, pp. 195-202, 2014.
17. T. Kawasaki and T. Kawai, "Toll-like receptor signaling pathways, " Frontiers in Immunology, vol. 5, article 461, 2014.
18. V. Motta, F. Soares, T. Sun, and D. J. Philpott, "Nod-like receptors: versatile cytosolic sentinels, " Physiological Reviews, vol. 95, no. 1, pp. 149-178, 2015.
19. G.Y. Chen and G. Nez, "Inflammasomes in intestinal inflammation and cancer, " Gastroenterology, vol. 141, no. 6, pp. 1986-1999, 2011.
20. M. Miyara and S. Sakaguchi, "Human FoxP3+CD4+ regulatory T cells: their knowns and unknowns, " Immunology and Cell Biology, vol. 89, no. 3, pp. 346-351, 2011.
21. S. Sakaguchi, M. Miyara, C. M. Costantino, and D. A. Hafler, "FOXP3+ regulatory T cells in the human immune system, " Nature Reviews Immunology, vol. 10, no. 7, pp. 490-500, 2010.
22. N. Arpaia, C. Campbell, X. Fan et al., "Metabolites produced by commensal bacteria promote peripheral regulatory T-cell generation, " Nature, vol. 504, no. 7480, pp. 451-455, 2013.
23. Y. Furusawa, Y. Obata, S. Fukuda et al., "Commensal microbederived butyrate induces the differentiation of colonic regulatory T cells, " Nature, vol. 504, no. 7480, pp. 446-450, 2013.
24. K. Atarashi, T. Tanoue, T. Shima et al., "Induction of colonic regulatory T cells by indigenous Clostridium species, " Science, vol. 331, no. 6015, pp. 337-341, 2011.
25. K. Atarashi, T. Tanoue, K. Oshima et al., "Treg induction by a rationally selectedmixture of Clostridia strains fromthe human microbiota, " Nature, vol. 500, no. 7461, pp. 232-236, 2013.
26. M. J. Blaser, "Equilibria of humans and our indigenous microbiota affecting asthma, " Proceedings of the American Thoracic Society, vol. 9, no. 2, pp. 69-71, 2012.
27. Y. Chen and M. J. Blaser, "Inverse associations of Helicobacter pylori with asthma and allergy, " Archives of Internal Medicine, vol. 167, no. 8, pp. 821-827, 2007.
28. J. Reibman, M. Marmor, J. Filner et al., "Asthma is inversely associated with Helicobacter pylori status in an urban population, " PLoS ONE, vol. 3, no. 12, Article IDe4060, 2008.
29. I. C. Arnold, N. Dehzad, S. Reuter et al., "Helicobacter pylori infection prevents allergic asthma in mousemodels through the induction of regulatory T cells, " Journal of Clinical Investigation, vol. 121, no. 8, pp. 3088-3093, 2011.
30. D. Rothenbacher, M. J. Blaser, G. Bode, and H. Brenner, "Inverse relationship between gastric colonization of Helicobacter pylori and diarrheal illnesses in children: results of a population-based cross-sectional study, "TheJournal of InfectiousDiseases, vol. 182, no. 5, pp. 1446-1449, 2000.
31. S. Perry, B. C. de Jong, J. V. Solnick et al., "Infection with Helicobacter pylori is associated with protection against tuberculosis, " PLoS ONE, vol. 5, no. 1, Article ID e8804, 2010.
32. J. J. Faith, P. P. Ahern, V. K. Ridaura, J. Cheng, and J. I. Gordon, "Identifying gutmicrobe-host phenotype relationships using combinatorial communities in gnotobiotic mice, " Science Translational Medicine, vol. 6, no. 220, Article ID 220ra11, 2014.
33. N. Tai, F. S. Wong, and L. Wen, "The role of gut microbiota in the development of type 1, type 2 diabetes mellitus and obesity, " Reviews in Endocrine and Metabolic Disorders, vol. 16, no. 1, pp. 55-65, 2015.
34. J. R. Angelo, M.-I. Guerrero-Zayas, and K. D. Tremblay, "A fate map of the murine pancreas buds reveals a multipotent ventral foregut organ progenitor, " PLoS ONE, vol. 7, no. 7, Article ID e40707, 2012.
35. O. Lioubinski, M. Müller, M. Wegner, and M. Sander, "Expression of Sox transcription factors in the developing mouse pancreas, " Developmental Dynamics, vol. 227, no. 3, pp. 402-408, 2003.
36. R. L. Pictet, W. R. Clark, R. H. Williams, andW. J. Rutter, "An ultrastructural analysis of the developing embryonic pancreas, " Developmental Biology, vol. 29, no. 4, pp. 436-467, 1972.
37. G. Kesavan, F. W. Sand, T. U. Greiner et al., "Cdc42-mediated tubulogenesis controls cell specification, " Cell, vol. 139, no. 4, pp. 791-801, 2009.
38. A.-C. Hick, J. M. van Eyll, S. Cordi et al., "Mechanism of primitive duct formation in the pancreas and submandibular glands: a role for SDF-1, " BMC Developmental Biology, vol. 9, article 66, 2009.
39. H. W. Park and M. G. Lee, "Transepithelial bicarbonate secretion: lessons fromthe pancreas, " Cold SpringHarbor Perspectives in Medicine, vol. 2, no. 10, Article IDa009571, 2012.
40. V. M. Schwitzgebel, "Programming of the pancreas, " Molecular and Cellular Endocrinology, vol. 185, no. 1-2, pp. 99-108, 2001.
41. T. Murakami and T. Fujita, "Microcirculation of the rat pancreas, with special reference to the insulo-acinar portal and insulo-venous drainage systems: a further scanning electron microscope study of corrosion casts, " Archives of Histology and Cytology, vol. 55, no. 5, pp. 453-476, 1992.
42. G. Jiang and B. B. Zhang, "Glucagon and regulation of glucose metabolism, " The American Journal of Physiology-Endocrinology & Metabolism, vol. 284, no. 4, pp. E671-E678, 2003.
43. C. Ciudad, M. Camici, Z. Ahmad, Y. Wang, A. A. DePaoli- Roach, and P. J. Roach, "Control of glycogen synthase phosphorylation in isolated rat hepatocytes by epinephrine, vasopressin and glucagon, " European Journal of Biochemistry, vol. 142, no. 3, pp. 511-520, 1984.
44. A. Martinez, C. Weaver, J. López et al., "Regulation of insulin secretion and blood glucose metabolism by adrenomedullin, " Endocrinology, vol. 137, no. 6, pp. 2626-2632, 1996.
45. R. S. Heller, M. Jenny, P. Collombat et al., "Genetic determinants of pancreatic ε-cell development, " Developmental Biology, vol. 286, no. 1, pp. 217-224, 2005.
46. A. R. Pandiri, "Overview of exocrine pancreatic pathobiology, " Toxicologic Pathology, vol. 42, no. 1, pp. 207-216, 2014.
47. R. Burcelin, "The gut-brain axis: a major glucoregulatory player, " Diabetes and Metabolism, vol. 36, supplement 3, pp. S54-S58, 2010.
48. A. F. Peery, E. S. Dellon, J. Lund et al., "Burden of gastrointestinal disease in the United States: 2012 update, " Gastroenterology, vol. 143, no. 5, pp. 1179.e3-1187.e3, 2012.
49. D. Yadav and A. B. Lowenfels, "Trends in the epidemiology of the first attack of acute pancreatitis: a systematic review, " Pancreas, vol. 33, no. 4, pp. 323-330, 2006.
50. D. Yadav and A. B. Lowenfels, "The epidemiology of pancreatitis and pancreatic cancer, " Gastroenterology, vol. 144, no. 6, pp. 1252-1261, 2013.
51. H. Liu, W. Li, X. Wang, J. Li, and W. Yu, "Early gut mucosal dysfunction in patients with acute pancreatitis, " Pancreas, vol. 36, no. 2, pp. 192-196, 2008.
52. S. H. Rahman, B. J. Ammori, M. Larvin, and M. J. McMahon, "Increased nitric oxide excretion in patients with severe acute pancreatitis: evidence of an endotoxin mediated inflammatory response?" Gut, vol. 52, no. 2, pp. 270-274, 2003.
53. P. Dítě, M. Hermanová, J. Trna et al., "The role of chronic inflammation: chronic pancreatitis as a risk factor of pancreatic cancer, " Digestive Diseases, vol. 30, no. 3, pp. 277-283, 2012.
54. R. Hoque, A. F. Malik, F. Gorelick, and W. Z. Mehal, "Sterile inflammatory response in acute pancreatitis, " Pancreas, vol. 41, no. 3, pp. 353-357, 2012.
55. A. Tsung, R. Sahai, H. Tanaka et al., "The nuclear factor HMGB1 mediates hepatic injury after murine liver ischemiareperfusion, " The Journal of ExperimentalMedicine, vol. 201, no. 7, pp. 1135-1143, 2005.
56. Á. K. Kocsis, A. Szabolcs, P. Hofner et al., "Plasma concentrations of high-mobility group box protein 1, soluble receptor for advanced glycation end-products and circulating DNA in patients with acute pancreatitis, " Pancreatology, vol. 9, no. 4, pp. 383-391, 2009.
57. T. Yasuda, T. Ueda, Y. Takeyama et al., "Significant increase of serum high-mobility group box chromosomal protein 1 levels in patients with severe acute pancreatitis, " Pancreas, vol. 33, no. 4, pp. 359-363, 2006.
58. J.-M. Song, H.-X. Liu, Y. Li et al., "Extracellular heat-shock protein 70 aggravates cerulein-induced pancreatitis through tolllike receptor-4 in mice, " Chinese Medical Journal, vol. 121, no. 15, pp. 1420-1425, 2008.
59. S.-Q. Ding, Y. Li, Z.-G. Zhou, C. Wang, L. Zhan, and B. Zhou, "Toll-like receptor 4-mediated apoptosis of pancreatic cells in cerulein-induced acute pancreatitis in mice, " Hepatobiliary and Pancreatic Diseases International, vol. 9, no. 6, pp. 645-650, 2010.
60. R. M. Minter, M. A. Ferry, M. E. Murday et al., "Adenoviral delivery of human and viral IL-10 in murine sepsis, " Journal of Immunology, vol. 167, no. 2, pp. 1053-1059, 2001.
61. A. Nishio, M. Asada, K. Uchida, T. Fukui, T. Chiba, and K. Okazaki, "The role of innate immunity in the pathogenesis of experimental autoimmune pancreatitis in mice, " Pancreas, vol. 40, no. 1, pp. 95-102, 2011.
62. K. S. Midwood and A.M. Piccinini, "DAM Pening inflammation by modulating TLR signalling, " Mediators of Inflammation, vol. 2010, Article ID672395, 21 pages, 2010.
63. P. Duewell, H. Kono, K. J. Rayner et al., "NLRP3 inflammasomes are required for atherogenesis and activated by cholesterol crystals, " Nature, vol. 464, no. 7293, pp. 1357-1361, 2010.
64. J. Norman, M. Franz, J. Messina et al., "Interleukin-1 receptor antagonist decreases severity of experimental acute pancreatitis, " Surgery, vol. 117, no. 6, pp. 648-655, 1995.
65. J. G. Norman, G. Fink, M. Franz et al., "Active interleukin-1 receptor required for maximal progression of acute pancreatitis, " Annals of Surgery, vol. 223, no. 2, pp. 163-169, 1996.
66. F. Marrache, S. P. Tu, G. Bhagat et al., "Overexpression of interleukin-1β in the murine pancreas results in chronic pancreatitis, " Gastroenterology, vol. 135, no. 4, pp. 1277-1287, 2008.
67. U. Wereszczynska-Siemiatkowska, B. Mroczko, and A. Siemiatkowski, "Serum profiles of interleukin-18 in different severity forms of human acute pancreatitis, " Scandinavian Journal of Gastroenterology, vol. 37, no. 9, pp. 1097-1102, 2002.
68. T. Ueda, Y. Takeyama, T. Yasuda et al., "Significant elevation of serum interleukin-18 levels in patients with acute pancreatitis, " Journal of Gastroenterology, vol. 41, no. 2, pp. 158-165, 2006.
69. N. Ueno, S.-I. Kashiwamura, H. Ueda et al., "Role of interleukin 18 in nitric oxide production and pancreatic damage during acute pancreatitis, " Shock, vol. 24, no. 6, pp. 564-570, 2005.
70. A. Matas-Cobos, E. Redondo-Cerezo, C. Alegría-Motte et al., "The role of Toll-like receptor polymorphisms in acute pancreatitis occurrence and severity, " Pancreas, vol. 44, no. 3, pp. 429-433, 2015.
71. Z.-Z. Guo, P. Wang, Z.-H. Yi, Z.-Y. Huang, and C.-W. Tang, "The crosstalk between gut inflammation and gastrointestinal disorders during acute pancreatitis, " Current Pharmaceutical Design, vol. 20, no. 7, pp. 1051-1062, 2014.
72. B. J. Ammori, P. C. Leeder, R. F. G. J. King et al., "Early increase in intestinal permeability in patients with severe acute pancreatitis: correlation with endotoxemia, organ failure, and mortality, " Journal of Gastrointestinal Surgery, vol. 3, no. 3, pp. 252-262, 1999.
73. J.-L. Frossard, M. L. Steer, and C.M. Pastor, "Acute pancreatitis, " The Lancet, vol. 371, no. 9607, pp. 143-152, 2008.
74. J.W. Rychter, L. P. Van Minnen, A. Verheem et al., "Pretreatment but not treatment with probiotics abolishes mouse intestinal barrier dysfunction in acute pancreatitis, " Surgery, vol. 145, no. 2, pp. 157-167, 2009.
75. K. Yoshida, F. Toki, T. Takeuchi, S.-I. Watanabe, K. Shiratori, and N. Hayashi, "Chronic pancreatitis caused by an autoimmune abnormality. Proposal of the concept of autoimmune pancreatitis, " Digestive Diseases and Sciences, vol. 40, no. 7, pp. 1561-1568, 1995.
76. B. Etemad and D. C. Whitcomb, "Chronic pancreatitis: diagnosis, classification, and new genetic developments, " Gastroenterology, vol. 120, no. 3, pp. 682-707, 2001.
77. H. Hamano, S. Kawa, A. Horiuchi et al., "High serum IgG4 concentrations in patients with sclerosing pancreatitis, " The New England Journal of Medicine, vol. 344, no. 10, pp. 732-738, 2001.
78. L. Aparisi, A. Farre, L. Gomez-Cambronero et al., "Antibodies to carbonic anhydrase and IgG4 levels in idiopathic chronic pancreatitis: relevance for diagnosis of autoimmune pancreatitis, " Gut, vol. 54, no. 5, pp. 703-709, 2005.
79. G. Klöppel, J. Lüttges, M. Löhr, G. Zamboni, and D. Longnecker, "Autoimmune pancreatitis: pathological, clinical, and immunological features, " Pancreas, vol. 27, no. 1, pp. 14-19, 2003.
80. J. Kountouras, G. Deretzi, C. Zavos et al., "Association between Helicobacter pylori infection and acute inflammatory demyelinating polyradiculoneuropathy, " European Journal ofNeurology, vol. 12, no. 2, pp. 139-143, 2005.
81. J. Kountouras, C. Zavos, and D. Chatzopoulos, "Autoimmune pancreatitis, Helicobacter pylori infection, andapoptosis: a proposed relationship, " Pancreas, vol. 30, no. 2, pp. 192-193, 2005.
82. F. Guarneri, C. Guarneri, and S. Benvenga, "Helicobacter pylori and autoimmune pancreatitis: role of carbonic anhydrase via molecular mimicry?" Journal of Cellular and Molecular Medicine, vol. 9, no. 3, pp. 741-744, 2005.
83. S. Watanabe, K. Suzuki, Y. Kawauchi et al., "Kinetic analysis of the development of pancreatic lesions in mice infected with a murine retrovirus, " Clinical Immunology, vol. 109, no. 2, pp. 212-223, 2003.
84. K. Suzuki and M. Fujiwara, "Exocrinopathy resembling Sjögren's syndrome induced by a murine retrovirus, " Nippon Rinsho, vol. 53, no. 10, pp. 2461-2466, 1995.
85. I. Haruta, N. Yanagisawa, S. Kawamura et al., "Amousemodel of autoimmune pancreatitis with salivary gland involvement triggered by innate immunity via persistent exposure to avirulent bacteria, " Laboratory Investigation, vol. 90, no. 12, pp. 1757-1769, 2010.
86. W.-M. Qu, T. Miyazaki, M. Terada et al., "A novel autoimmune pancreatitis model in MRL mice treated with polyinosinic: polycytidylic acid, " Clinical & Experimental Immunology, vol. 129, no. 1, pp. 27-34, 2002.
87. A. Masamune, K. Kikuta, T. Watanabe, K. Satoh, A. Satoh, and T. Shimosegawa, "Pancreatic stellate cells express Toll-like receptors, " Journal of Gastroenterology, vol. 43, no. 5, pp. 352-362, 2008.
88. L. Frulloni, C. Lunardi, R. Simone et al., "Identification of a novel antibody associated with autoimmune pancreatitis, " The New England Journal ofMedicine, vol. 361, no. 22, pp. 2135-2142, 2009.
89. Y. Fukui, K. Uchida, Y. Sakaguchi et al., "Possible involvement of Toll-like receptor 7 in the development of type 1 autoimmune pancreatitis, " Journal of Gastroenterology, vol. 50, no. 4, pp. 435-444, 2014.
90. J.-L. Ding, Z.-G. Zhou, X.-Y. Zhou et al., "Attenuation of acute pancreatitis by peroxisome proliferator-activated receptor-α in rats: the effect on toll-like receptor signaling pathways, " Pancreas, vol. 42, no. 1, pp. 114-122, 2013.
91. R. Hoque, A. Farooq, A. Ghani, F. Gorelick, and W. Z. Mehal, "Lactate reduces liver and pancreatic injury in toll-like receptorand inflammasome-mediated inflammation via gpr81-mediated suppression of innate immunity, " Gastroenterology, vol. 146, no. 7, pp. 1763-1774, 2014.
92. V. A. Gorskii, M. A. Agapov, M. V. Khoreva, V. A. Petrov, A. Y. Kravchenko, and A. I. Battaev, "Effect of lornoxicam therapy on expression of TLR2 and TLR4 mRNA during systemic complications of acute pancreatitis, " Bulletin of Experimental Biology and Medicine, vol. 158, no. 1, pp. 13-15, 2014.
93. B. J. Ammori, "Role of the gut in the course of severe acute pancreatitis, " Pancreas, vol. 26, no. 2, pp. 122-129, 2003.
94. A. Jemal, F. Bray, M. M. Center, J. Ferlay, E. Ward, and D. Forman, "Global cancer statistics, " CA Cancer Journal for Clinicians, vol. 61, no. 2, pp. 69-90, 2011.
95. D. Hariharan, A. Saied, and H.M. Kocher, "Analysis ofmortality rates for pancreatic cancer across the world, " HPB, vol. 10, no. 1, pp. 58-62, 2008.
96. L.B. Zeni, R. F. Russi, A. F. Fialho, A.L.P. Fonseca, L.S. Sombrio, and I. C. Rocha, "Morbidity andmortality of pancreatic tumors undergoing surgical treatment, " Arquivos Brasileiros de Cirurgia Digestiva, vol. 27, no. 4, pp. 275-279, 2014.
97. D. P. S. Sohal, S. Shrotriya, K. T. Glass et al., "Predicting early mortality in resectable pancreatic adenocarcinoma: a cohort study, " Cancer, vol. 121, no. 11, pp. 1779-1784, 2015.
98. M. Hidalgo, S. Cascinu, J. Kleeff et al., "Addressing the challenges of pancreatic cancer: future directions for improving outcomes, " Pancreatology, vol. 15, no. 1, pp. 8-18, 2015.
99. M. Löhr, "Is it possible to survive pancreatic cancer?" Nature Clinical Practice Gastroenterology & Hepatology, vol. 3, no. 5, pp. 236-237, 2006.
100. A. E. Becker, Y. G. Hernandez, H. Frucht, and A. L. Lucas, "Pancreatic ductal adenocarcinoma: risk factors, screening, and early detection, " World Journal of Gastroenterology, vol. 20, no. 32, pp. 11182-11198, 2014.
101. American Cancer Society, Cancer Facts & Figures 2013, American Cancer Society, Atlanta, Ga, USA, 2014.
102. A. L. Mulkeen, P. S. Yoo, and C. Cha, "Less common neoplasms of the pancreas, " World Journal of Gastroenterology, vol. 12, no. 20, pp. 3180-3185, 2006.
103. N. I. Kondo and Y. Ikeda, "Practicalmanagement and treatment of pancreatic neuroendocrine tumors, " Gland Surgery, vol. 3, no. 4, pp. 276-283, 2014.
104. L. R. McKenna and B. H. Edil, "Update on pancreatic neuroendocrine tumors, " Gland Surgery, vol. 3, no. 4, pp. 258-275, 2014.
105. F. J. Service, M. M. McMahon, P. C. O'Brien, and D. J. Ballard, "Functioning insulinoma-incidence, recurrence, and long-term survival of patients: a 60-year study, " Mayo Clinic Proceedings, vol. 66, no. 7, pp. 711-719, 1991.
106. A. Wild, P. Langer, A. Ramaswamy, B. Chaloupka, and D. K. Bartsch, "A novel insulinoma tumor suppressor gene locus on chromosome 22q with potential prognostic implications, " Journal of Clinical Endocrinology and Metabolism, vol. 86, no. 12, pp. 5782-5787, 2001.
107. P. Kar, P. Price, S. Sawers, S. Bhattacharya, R. H. Reznek, and A. B. Grossman, "Insulinomas may present with normoglycemia after prolonged fasting but glucose-stimulated hypoglycemia, " Journal of Clinical Endocrinology and Metabolism, vol. 91, no. 12, pp. 4733-4736, 2006.
108. A. Aynsley-Green, K. J. Lindley, K. Hussain et al., "Practical management of hyperinsulinism in infancy, " Archives of Disease inChildhood: Fetal andNeonatal Edition, vol. 82, no. 2, pp. F98-F107, 2000.
109. C. James, R. R. Kapoor, D. Ismail, and K. Hussain, "The genetic basis of congenital hyperinsulinism, " Journal of Medical Genetics, vol. 46, no. 5, pp. 289-299, 2009.
110. K. Hojlund, T. Hansen, M. Lajer et al., "A novel syndrome of autosomal-dominant hyperinsulinemic hypoglycemia linked to a mutation in the human insulin receptor gene, " Diabetes, vol. 53, no. 6, pp. 1592-1598, 2004.
111. F. J. Service, N. Natt, G. B. Thompson et al., "Noninsulinoma pancreatogenous hypoglycemia: a novel syndrome of hyperinsulinemic hypoglycemia in adults independent of mutations in Kir6.2 and SUR1 genes, " Journal of Clinical Endocrinology and Metabolism, vol. 84, no. 5, pp. 1582-1589, 1999.
112. J. M. Uronis, M. Mühlbauer, H. H. Herfarth, T. C. Rubinas, G. S. Jones, and C. Jobin, "Modulation of the intestinal microbiota alters colitis-associated colorectal cancer susceptibility, " PLoS ONE, vol. 4, no. 6, Article ID e6026, 2009.
113. Y. Li, P. Kundu, S. W. Seow et al., "Gut microbiota accelerate tumor growth via c-jun and STAT3 phosphorylation in APCMin/+ mice, " Carcinogenesis, vol. 33, no. 6, pp. 1231-1238, 2012.
114. R. F. Schwabe and C. Jobin, "The microbiome and cancer, " Nature Reviews Cancer, vol. 13, no. 11, pp. 800-812, 2013.
115. J. J. Farrell, L. Zhang, H. Zhou et al., "Variations of oral microbiota are associated with pancreatic diseases including pancreatic cancer, " Gut, vol. 61, no. 4, pp. 582-588, 2012.
116. S. I. Grivennikov, F. R. Greten, and M. Karin, "Immunity, inflammation, and cancer, " Cell, vol. 140, no. 6, pp. 883-899, 2010.
117. G. Trinchieri, "Cancer and inflammation: An old intuition with rapidly evolving new concepts, " Annual Review of Immunology, vol. 30, pp. 677-706, 2012.
118. J. L. Lofgren, M. T. Whary, Z. Ge et al., "Lack of commensal flora in helicobacter pylori-infected INS-GAS mice reduces gastritis and delays intraepithelial neoplasia, " Gastroenterology, vol. 140, no. 1, pp. 210-220, 2011.
119. K. Klimesova, M. Kverka, Z. Zakostelska et al., "Altered gut microbiota promotes colitis-associated cancer in IL-1 receptorassociated kinase m-deficient mice, " Inflammatory Bowel Diseases, vol. 19, no. 6, pp. 1266-1277, 2013.
120. P. S. Moore and Y. Chang, "Why do viruses cause cancer? Highlights of the first century of human tumour virology, " Nature Reviews Cancer, vol. 10, no. 12, pp. 878-889, 2010.
121. B. Hu, E. Elinav, S. Huber et al., "Microbiota-induced activation of epithelial IL-6 signaling links inflammasome-driven inflammation with transmissible cancer, " Proceedings of the National Academy of Sciences of the United States of America, vol. 110, no. 24, pp. 9862-9867, 2013.
122. A. Couturier-Maillard, T. Secher, A. Rehman et al., "NOD2- mediated dysbiosis predisposes mice to transmissible colitis and colorectal cancer, " Journal of Clinical Investigation, vol. 123, no. 2, pp. 700-711, 2013.
123. F. Balkwill and A. Mantovani, "Inflammation and cancer: back to Virchow?" The Lancet, vol. 357, no. 9255, pp. 539-545, 2001.
124. D. K. Bartsch, T. M. Gress, and P. Langer, "Familial pancreatic cancer-current knowledge, " Nature Reviews Gastroenterology & Hepatology, vol. 9, no. 8, pp. 445-453, 2012.
125. M. Löhr, G. Klöppel, P. Maisonneuve, A. B. Lowenfels, and J. Lüttges, "Frequency of K-ras mutations in pancreatic intraductal neoplasias associated with pancreatic ductal adenocarcinoma and chronic pancreatitis: a meta-analysis, " Neoplasia, vol. 7, no. 1, pp. 17-23, 2005.
126. C. Carrière, A. L. Young, J. R. Gunn, D. S. Longnecker, and M. Korc, "Acute pancreatitis markedly accelerates pancreatic cancer progression in mice expressing oncogenic Kras, " Biochemical and Biophysical Research Communications, vol. 382, no. 3, pp. 561-565, 2009.
127. C. Guerra, A. J. Schuhmacher, M. Cañamero et al., "Chronic pancreatitis is essential for induction of pancreatic ductal adenocarcinoma by K-Ras oncogenes in adult mice, " Cancer Cell, vol. 11, no. 3, pp. 291-302, 2007.
128. J. Daniluk, Y. Liu, D. Deng et al., "AnNF-κB pathway-mediated positive feedback loop amplifies Ras activity to pathological levels in mice, " Journal of Clinical Investigation, vol. 122, no. 4, pp. 1519-1528, 2012.
129. H. Huang, J. Daniluk, Y. Liu et al., "Oncogenic K-Ras requires activation for enhanced activity, " Oncogene, vol. 33, no. 4, pp. 532-535, 2014.
130. T. Guina, F. Biasi, S. Calfapietra, M. Nano, and G. Poli, "Inflammatory and redox reactions in colorectal carcinogenesis, " Annals of the New York Academy of Sciences, vol. 1340, no. 1, pp. 95-103, 2015.
131. H. Yu, D. Pardoll, and R. Jove, "STATs in cancer inflammation and immunity: a leading role for STAT3, " Nature Reviews Cancer, vol. 9, no. 11, pp. 798-809, 2009.
132. G. Rieder, A. Karnholz, M. Stoeckelhuber, J. L. Merchant, and R. Haas, "H pylori infection causes chronic pancreatitis in Mongolian gerbils, " World Journal of Gastroenterology, vol. 13, no. 29, pp. 3939-3947, 2007.
133. H. A. Risch, L. Lu, M. S. Kidd et al., "Helicobacter pylori seropositivities and risk of pancreatic carcinoma, " Cancer Epidemiology Biomarkers and Prevention, vol. 23, no. 1, pp. 172-178, 2014.
134. B. Lindkvist, D. Johansen, A. Borgström, and J. Manjer, "A prospective study of Helicobacter pylori in relation to the risk for pancreatic cancer, " BMC Cancer, vol. 8, article 321, 2008.
135. G. Yu, G. Murphy, A. Michel et al., "Seropositivity to Helicobacter pylori and risk of pancreatic cancer, " Cancer Epidemiology Biomarkers and Prevention, vol. 22, no. 12, pp. 2416-2419, 2013.
136. H.-O. Nilsson, T. Wadström, U. Stenram, and I. Ihse, "Helicobacter species ribosomal DNA in the pancreas, stomach and duodenum of pancreatic cancer patients, " World Journal of Gastroenterology, vol. 12, no. 18, pp. 3038-3043, 2006.
137. W. Wang, J. L. Abbruzzese, D. B. Evans, L. Larry, K. R. Cleary, andP. J. Chiao, "Thenuclear factor-κB RelAtranscription factor is constitutively activated in human pancreatic adenocarcinoma cells, " Clinical Cancer Research, vol. 5, no. 1, pp. 119-127, 1999.
138. N. Yamanaka, T. Morisaki, H. Nakashima et al., "Interleukin 1βenhances invasive ability of gastric carcinoma through nuclear factor-κB activation, " Clinical Cancer Research, vol. 10, no. 5, pp. 1853-1859, 2004.
139. M. Kojima, T. Morisaki, K. Izuhara et al., "Lipopolysaccharide increases cyclo-oxygenase-2 expression in a colon carcinoma cell line through nuclear factor-κB activation, " Oncogene, vol. 19, no. 9, pp. 1225-1231, 2000.
140. M. H. Fraher, P.W. O'Toole, and E.M.M. Quigley, "Techniques used to characterize the gut microbiota: a guide for the clinician, " Nature Reviews Gastroenterology & Hepatology, vol. 9, no. 6, pp. 312-322, 2012.
141. O. Takeuchi and S. Akira, "Pattern recognition receptors and inflammation, " Cell, vol. 140, no. 6, pp. 805-820, 2010.
142. M. Fukata, L. Shang, R. Santaolalla et al., "Constitutive activation of epithelial TLR4 augments inflammatory responses to mucosal injury and drives colitis-associated tumorigenesis, " Inflammatory Bowel Diseases, vol. 17, no. 7, pp. 1464-1473, 2011.
143. E. P. DiMagno, H. A. Reber, and M. A. Tempero, "AGA technical review on the epidemiology, diagnosis, and treatment of pancreatic ductal adenocarcinoma, " Gastroenterology, vol. 117, no. 6, pp. 1464-1484, 1999.
144. J. A. Aas, B. J. Paster, L.N. Stokes, I. Olsen, and F. E. Dewhirst, "Defining the normal bacterial flora of the oral cavity, " Journal of Clinical Microbiology, vol. 43, no. 11, pp. 5721-5732, 2005.
145. D. S. Michaud, K. Joshipura, E. Giovannucci, and C. S. Fuchs, "A prospective study of periodontal disease and pancreatic cancer in US male health professionals, " Journal of the National Cancer Institute, vol. 99, no. 2, pp. 171-175, 2007.
146. P. P. Hujoel, M. Drangsholt, C. Spiekerman, and N. S. Weiss, "An exploration of the periodontitis-cancer association, " Annals of Epidemiology, vol. 13, no. 5, pp. 312-316, 2003.
147. R. Z. Stolzenberg-Solomon, K.W. Dodd, M. J. Blaser, J. Virtamo, P. R. Taylor, and D. Albanes, "Tooth loss, pancreatic cancer, and Helicobacter pylori, " American Journal of Clinical Nutrition, vol. 78, no. 1, pp. 176-181, 2003.
148. J. F. Siqueira Jr. and I. N. Rôças, "Catonella morbi and Granulicatella adiacens: new species in endodontic infections, " Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology and Endodontology, vol. 102, no. 2, pp. 259-264, 2006.
149. P. S. Kumar, A. L. Griffen, J. A. Barton, B. J. Paster, M. L. Moeschberger, and E. J. Leys, "New bacterial species associated with chronic periodontitis, " Journal of Dental Research, vol. 82, no. 5, pp. 338-344, 2003.
150. D. S. Michaud, J. Izard, C. S. Wilhelm-Benartzi et al., "Plasma antibodies to oral bacteria and risk of pancreatic cancer in a large European prospective cohort study, " Gut, vol. 62, no. 12, pp. 1764-1770, 2013.
151. C. G. van Hoogmoed, H. C. van der Mei, and H. J. Busscher, "The influence of biosurfactants released by S. mitis BMS on the adhesion of pioneer strains and cariogenic bacteria, " Biofouling, vol. 20, no. 6, pp. 261-267, 2004.
152. J. D. Wong and J. M. Janda, "Association of an important Neisseria species, Neisseria elongata subsp. nitroreducens, with bacteremia, endocarditis, and osteomyelitis, " Journal of Clinical Microbiology, vol. 30, no. 3, pp. 719-720, 1992.
153. P. C.-Y. Woo, A. M.-Y. Fung, S. K.-P. Lau et al., "Granulicatella adiacens and Abiotrophia defectiva bacteraemia characterized by 16S rRNA gene sequencing, " Journal ofMedicalMicrobiology, vol. 52, no. 2, pp. 137-140, 2003.
154. F. C. Gibson III, H. Yumoto, Y. Takahashi, H.-H. Chou, and C. A. Genco, "Innate immune signaling and Porphyromonas gingivalis- accelerated atherosclerosis, " Journal of Dental Research, vol. 85, no. 2, pp. 106-121, 2006.
155. Y. Kusumoto, H. Hirano, K. Saitoh et al., "Human gingival epithelial cells produce chemotactic factors interleukin-8 and monocyte chemoattractant protein-1 after stimulation with Porphyromonas gingivalis via Toll-like receptor 2, " Journal of Periodontology, vol. 75, no. 3, pp. 370-379, 2004.
156. I. D. Federation, Diabetes Atlas 2003, IDF, 2003.
157. J. Karalliedde and L. Gnudi, "Diabetes mellitus, a complex and heterogeneous disease, and the role of insulin resistance as a determinant of diabetic kidney disease, " Nephrology Dialysis Transplantation, 2014.
158. P. Dandona, A. Aljada, and A. Bandyopadhyay, "Inflammation: the link between insulin resistance, obesity and diabetes, " Trends in Immunology, vol. 25, no. 1, pp. 4-7, 2004.
159. V. Parikka, K. Näntö-Salonen, M. Saarinen et al., "Early Seroconversion and rapidly increasing autoantibody concentrations predict prepubertal manifestation of type 1 diabetes in Children at genetic risk, " Diabetologia, vol. 55, no. 7, pp. 1926-1936, 2012.
160. K. T. Coppieters, F. Dotta, N. Amirian et al., "Demonstration of islet-autoreactive CD8 T cells in insulitic lesions from recent onset and long-term type 1 diabetes patients, " Journal of Experimental Medicine, vol. 209, no. 1, pp. 51-60, 2012.
161. B. O. Roep and T. I. M. Tree, "Immune modulation in humans: implications for type 1 diabetes mellitus, " Nature Reviews Endocrinology, vol. 10, no. 4, pp. 229-242, 2014.
162. M. A. Atkinson and N. K. Maclaren, "Mechanisms of disease: the pathogenesis of insulin-dependent diabetes mellitus, " The New England Journal ofMedicine, vol. 331, no. 21, pp. 1428-1436, 1994.
163. P. Arvan, M. Pietropaolo, D. Ostrov, and C. J. Rhodes, "Islet autoantigens: structure, function, localization, and regulation, " Cold SpringHarbor Perspectives inMedicine, vol. 2, no. 8, Article ID a007658, 2012.
164. T. Orban, J. M. Sosenko, D. Cuthbertson et al., "Pancreatic islet autoantibodies as predictors of type 1 diabetes in the diabetes prevention trial-type 1, " Diabetes Care, vol. 32, no. 12, pp. 2269-2274, 2009.
165. A. Zóka, G. Muzes, A. Somogyi et al., "Altered immune regulation in type 1 diabetes, "Clinical andDevelopmental Immunology, vol. 2013, Article ID 254874, 17 pages, 2013.
166. A. Pugliese, "The multiple origins of Type 1 diabetes, " Diabetic Medicine, vol. 30, no. 2, pp. 135-146, 2013.
167. J. A. Noble and H. A. Erlich, "Genetics of type 1 diabetes, " Cold Spring Harbor Perspectives in Medicine, vol. 2, no. 1, 2012.
168. I. Santin and D. L. Eizirik, "Candidate genes for type 1 diabetes modulate pancreatic islet inflammation and β-cell apoptosis, " Diabetes, Obesity andMetabolism, vol. 15, no. 3, pp. 71-81, 2013.
169. J. Storling and C. A. Brorsson, "Candidate genes expressed in human islets and their role in the pathogenesis of type 1 diabetes, " Current Diabetes Reports, vol. 13, no. 5, pp. 633-641, 2013.
170. M. Knip and O. Simell, "Environmental triggers of type 1 diabetes, " Cold Spring Harbor Perspectives in Biology, vol. 3, no. 7, pp. 1-15, 2011.
171. M. Orešič, S. Simell, M. Sysi-Aho et al., "Dysregulation of lipid and amino acid metabolism precedes islet autoimmunity in children who later progress to type 1 diabetes, " Journal of Experimental Medicine, vol. 205, no. 13, pp. 2975-2984, 2008.
172. M. Pflueger, T. Seppänen-Laakso, T. Suortti et al., "Age- and islet autoimmunity-associated differences in amino acid and lipid metabolites in children at risk for type 1 diabetes, " Diabetes, vol. 60, no. 11, pp. 2740-2747, 2011.
173. O. Vaarala, M. A. Atkinson, and J. Neu, "The 'perfect storm' for type 1 diabetes: the complex interplay between intestinal microbiota, gut permeability, andmucosal immunity, " Diabetes, vol. 57, no. 10, pp. 2555-2562, 2008.
174. M. Wallberg and A. Cooke, "Immune mechanisms in type 1 diabetes, " Trends in Immunology, vol. 34, no. 12, pp. 583-591, 2013.
175. E. A. M. Gale and K. M. Gillespie, "Diabetes and gender, " Diabetologia, vol. 44, no. 1, pp. 3-15, 2001.
176. C. C. Patterson, G. G. Dahlquist, E. Gyürüs, A. Green, and G. Soltész, "Incidence trends for childhood type 1 diabetes in Europe during 1989-2003 and predicted new cases 2005-20: a multicentre prospective registration study, " The Lancet, vol. 373, no. 9680, pp. 2027-2033, 2009.
177. C. King and N. Sarvetnick, "The incidence of type-1 diabetes in NOD mice is modulated by restricted flora not germ-free conditions, " PLoS ONE, vol. 6, no. 2, Article ID e17049, 2011.
178. T. U. Greiner, T. Hyötyläinen, M. Knip, F. Bäckhed, and M. Orešič, "The gut microbiota modulates glycaemic control and serum metabolite profiles in non-obese diabetic mice, " PLoS ONE, vol. 9, no. 11, Article ID e110359, 2014.
179. P. J. Sansonetti and J. P. Di Santo, "Debugging how bacteria manipulate the immune response, " Immunity, vol. 26, no. 2, pp. 149-161, 2007.
180. D. M. Adamczak, J. K. Nowak, M. Frydrychowicz, M. Kaczmarek, and J. Sikora, "The role of toll-like receptors and vitamin D indiabetesmellitus type 1-a review, " Scandinavian Journal of Immunology, vol. 80, no. 2, pp. 75-84, 2014.
181. L. Wen, R. E. Ley, P. Y. Volchkov et al., "Innate immunity and intestinal microbiota in the development of type 1 diabetes, " Nature, vol. 455, no. 7216, pp. 1109-1113, 2008.
182. S. Rakoff-Nahoum, J. Paglino, F. Eslami-Varzaneh, S. Edberg, and R. Medzhitov, "Recognition of commensal microflora by toll-like receptors is required for intestinal homeostasis, " Cell, vol. 118, no. 2, pp. 229-241, 2004.
183. H. M. Garay-Malpartida, R. F. Mourão, M. Mantovani, I. A. Santos, M. C. Sogayar, and A. C. Goldberg, "Toll-like receptor 4 (TLR4) expression in human and murine pancreatic betacells affects cell viability and insulin homeostasis, " BMC Immunology, vol. 12, article 18, 2011.
184. M. Vives-Pi, N. Somoza, J. Fernández-Alvarez et al., "Evidence of expression of endotoxin receptors CD14, toll-like receptors TLR4 and TLR2 and associated molecule MD-2 and of sensitivity to endotoxin (LPS) in islet beta cells, " Clinical and Experimental Immunology, vol. 133, no. 2, pp. 208-218, 2003.
185. J. Amyot, M. Semache, M. Ferdaoussi, G. Fontés, and V. Poitout, "Lipopolysaccharides impair insulin gene expression in isolated islets of langerhans via toll-like receptor-4 and nf-κb signalling, " PLoS ONE, vol. 7, no. 4, Article ID e36200, 2012.
186. S. U. Devaskar, S. J. Giddings, P. A. Rajakumar, L. R. Carnaghi, R. K. Menon, and D. S. Zahm, "Insulin gene expression and insulin synthesis in mammalian neuronal cells, " Journal of Biological Chemistry, vol. 269, no. 11, pp. 8445-8454, 1994.
187. Y. Lin, H. Lee, A. H. Berg, M. P. Lisanti, L. Shapiro, and P. E. Scherer, "The lipopolysaccharide-activated Toll-like receptor (TLR)-4 induces synthesis of the closely related receptor TLR-2 in adipocytes, "The Journal of Biological Chemistry, vol. 275, no. 32, pp. 24255-24263, 2000.
188. A. M. Caricilli, P. K. Picardi, L. L. de Abreu et al., "Gut microbiota is a keymodulator of insulin resistance in TLR 2 knockout mice, " PLoS Biology, vol. 9, no. 12, Article IDe1001212, 2011.
189. P. J. Turnbaugh, R. E. Ley, M. A. Mahowald, V. Magrini, E. R. Mardis, and J. I. Gordon, "An obesity-associated gut microbiome with increased capacity for energy harvest, " Nature, vol. 444, no. 7122, pp. 1027-1031, 2006.
190. P. D. Cani, S. Possemiers, T. Van de Wiele et al., "Changes in gut microbiota control inflammation in obese mice through a mechanism involving GLP-2-driven improvement of gut permeability, " Gut, vol. 58, no. 8, pp. 1091-1103, 2009.
191. Z. Wang, G. Xiao, Y. Yao, S. Guo, K. Lu, and Z. Sheng, "The role of bifidobacteria in gut barrier function after thermal injury in rats, " Journal of Trauma, vol. 61, no. 3, pp. 650-657, 2006.
192. N. Larsen, F. K. Vogensen, F. W. J. Van Den Berg et al., "Gut microbiota in human adults with type 2 diabetes differs from non-diabetic adults, " PLoS ONE, vol. 5, no. 2, Article ID e9085, 2010.
193. D. Endesfelder, W. Z. Castell, A. Ardissone et al., "Compromised gut microbiota networks in children with anti-islet cell autoimmunity, " Diabetes, vol. 63, no. 6, pp. 2006-2014, 2014.
194. A. G. Davis-Richardson, A. N. Ardissone, R. Dias et al., "Bacteroides dorei dominates gut microbiome prior to autoimmunity in Finnish children at high risk for type 1 diabetes, " Frontiers in Microbiology, vol. 5, article 678, 2014.
195. C. T. Brown, A. G. Davis-Richardson, A. Giongo et al., "Gut microbiome metagenomics analysis suggests a functional model for the development of autoimmunity for type 1 diabetes, " PLoS ONE, vol. 6, no. 10, Article ID e25792, 2011.
196. H.M. Hamer, D. Jonkers, K. Venema, S. Vanhoutvin, F. J. Troost, and R.-J. Brummer, "Review article: the role of butyrate on colonic function, " Alimentary Pharmacology and Therapeutics, vol. 27, no. 2, pp. 104-119, 2008.
197. S. E. Pryde, S. H. Duncan, G. L. Hold, C. S. Stewart, and H. J. Flint, "The microbiology of butyrate formation in the human colon, " FEMS Microbiology Letters, vol. 217, no. 2, pp. 133-139, 2002.
198. K. Lewis, F. Lutgendorff, V. Phan, J. D. Söderholm, P. M. Sherman, and D. M. McKay, "Enhanced translocation of bacteria across metabolically stressed epithelia is reduced by butyrate, " Inflammatory Bowel Diseases, vol. 16, no. 7, pp. 1138-1148, 2010.
199. L. Peng, Z. He, W. Chen, I. R. Holzman, and J. Lin, "Effects of butyrate on intestinal barrier function in a caco-2 cell monolayer model of intestinal barrier, " Pediatric Research, vol. 61, no. 1, pp. 37-41, 2007.
200. A. Barcelo, J. Claustre, F. Moro, J.-A. Chayvialle, J.-C. Cuber, and P. Plaisancié, "Mucin secretion is modulated by luminal factors in the isolated vascularly perfused rat colon, " Gut, vol. 46, no. 2, pp. 218-224, 2000.
201. A. Shimotoyodome, S. Meguro, T. Hase, I. Tokimitsu, and T. Sakata, "Short chain fatty acids but not lactate or succinate stimulate mucus release in the rat colon, " Comparative Biochemistry and Physiology-A Molecular and Integrative Physiology, vol. 125, no. 4, pp. 525-531, 2000.
202. R. Wirth, N. Bódi, G. Maróti et al., "Regionally distinct alterations in the composition of the gut microbiota in rats with streptozotocin-induced diabetes, " PLoS ONE, vol. 9, no. 12, Article ID e110440, 2014.
203. F. Balzola, C. Bernstein, and G. Van Assche, "Role of Klebsiella and collagens in Crohn's disease: a new prospect in the use of low-starch diet-commentary, " Inflammatory Bowel Disease Monitor, vol. 10, no. 2, p. 67, 2009.
204. M. V. Vasseur, M. Laurentie, J.-G. Rolland et al., "Low or high doses of cefquinome targeting lowor high bacterial inocula cure Klebsiella pneumoniae lung infections but differentially impact the levels of antibiotic resistance in fecal flora, " Antimicrobial Agents and Chemotherapy, vol. 58, no. 3, pp. 1744-1748, 2014.
205. O. Vaarala, "Gut microbiota and type 1 diabetes, " Review of Diabetic Studies, vol. 9, no. 4, pp. 251-259, 2012.
206. K. J. Wolf, J. G. Daft, S. M. Tanner, R. Hartmann, E. Khafipour, and R. G. Lorenz, "Consumption of acidic water alters the gut microbiome and decreases the risk of diabetes in NOD mice, " Journal of Histochemistry and Cytochemistry, vol. 62, no. 4, pp. 237-250, 2014.
207. E.V. Marietta, A. M. Gomez, C. Yeoman et al., "Lowincidence of spontaneous type 1 diabetes in non-obese diabetic mice raised on gluten-free diets is associated with changes in the intestinal microbiome, " PLoS ONE, vol. 8, no. 11, Article ID e78687, 2013.
208. M. E. Andrade, R. S. Araújo, P. A. de Barros et al., "The role of immunomodulators on intestinal barrier homeostasis in experimental models, " Clinical Nutrition, 2015.
209. G. Stafford, S. Roy, K. Honma, and A. Sharma, "Sialic acid, periodontal pathogens and Tannerella forsythia: stick around and enjoy the feast!, " Molecular Oral Microbiology, vol. 27, no. 1, pp. 11-22, 2012.
210. C. Ubeda, V. Bucci, S. Caballero et al., "Intestinal microbiota containing Barnesiella species cures vancomycin-resistant Enterococcus faecium colonization, " Infection and Immunity, vol. 81, no. 3, pp. 965-973, 2013.
211. G. A. Weiss, C. Chassard, and T. Hennet, "Selective proliferation of intestinal Barnesiella under fucosyllactose supplementation in mice, " British Journal of Nutrition, vol. 111, no. 9, pp. 1602-1610, 2014.
212. F. F. Anhê, D. Roy, G. Pilon et al., "A polyphenol-rich cranberry extract protects from diet-induced obesity, insulin resistance and intestinal inflammation in association with increased Akkermansia spp. population in the gut microbiota of mice, " Gut, pp. 1-12, 2014.
213. S. L. Gorbach, "Probiotics and gastrointestinal health, " The American Journal of Gastroenterology, vol. 95, no. 1, pp. S2-S4, 2000.
214. M. S. Alokail, S. Sabico, Y. Al-Saleh et al., "Effects of probiotics in patients with diabetes mellitus type 2: study protocol for a randomized, double-blind, placebo-controlled trial, " Trials, vol. 14, article 195, 2013.
215. J. Amar, C. Chabo, A. Waget et al., "Intestinal mucosal adherence and translocation of commensal bacteria at the early onset of type 2 diabetes: molecular mechanisms and probiotic treatment, " EMBO Molecular Medicine, vol. 3, no. 9, pp. 559-572, 2011.
216. R. Valladares, D. Sankar, N. Li et al., "Lactobacillus johnsonii N6.2 mitigates the development of type 1 diabetes in BB-DP rats, " PLoS ONE, vol. 5, no. 5, Article ID e10507, 2010.
217. E. J. Ohlrich, M. P. Cullinan, and J. W. Leichter, "Diabetes, periodontitis, and the subgingival microbiota, " Journal of Oral Microbiology, vol. 2, 2010.
218. F. A. Gusberti, S. A. Syed, G. Bacon, N. Grossman, and W. J. Loesche, "Puberty gingivitis in insulin-dependent diabetic children. I. Cross-sectional observations, " Journal of Periodontology, vol. 54, no. 12, pp. 714-720, 1983.
219. M. Zhou, R. Rong, D. Munro et al., "Investigation of the effect of type 2 diabetes mellitus on subgingival plaque microbiota by high-throughput 16S rDNA pyrosequencing, " PLoS ONE, vol. 8, no. 4, Article ID e61516, 2013.
220. M. C. deGoffau, K. Luopajärvi, M. Knip et al., "Fecalmicrobiota composition differs between children with β-cell autoimmunity and those without, " Diabetes, vol. 62, no. 4, pp. 1238-1244, 2013.
221. P. Marteau and F. Shanahan, "Basic aspects and pharmacology of probiotics: an overview of pharmacokinetics, mechanisms of action and side-effects, " Bailliere's Best Practice and Research in Clinical Gastroenterology, vol. 17, no. 5, pp. 725-740, 2003.
222. A. C. Brown and A. Valiere, "Probiotics and medical nutrition therapy, "Nutrition inClinical Care, vol. 7, no. 2, pp. 56-68, 2004.
223. E. J. Schiffrin and S. Blum, "Interactions between the microbiota and the intestinal mucosa, " European Journal of Clinical Nutrition, vol. 56, supplement 3, pp. S60-S64, 2002.
224. L. P. van Minnen, H. M. Timmerman, F. Lutgendorff et al., "Modification of intestinal flora with multispecies probiotics reduces bacterial translocation and improves clinical course in a rat model of acute pancreatitis, " Surgery, vol. 141, no. 4, pp. 470-480, 2007.
225. F. Lutgendorff, L. M. Trulsson, L. P. van Minnen et al., "Probiotics enhance pancreatic glutathione biosynthesis and reduce oxidative stress in experimental acute pancreatitis, " The American Journal of Physiology-Gastrointestinal and Liver Physiology, vol. 295, no. 5, pp. G1111-G1121, 2008.
226. C. R. Hooijmans, R. B. M. de Vries, M. M. Rovers, H. G. Gooszen, and M. Ritskes-Hoitinga, "The effects of probiotic supplementation on experimental acute pancreatitis: a systematic review and meta-analysis, " PLoS ONE, vol. 7, no. 11, Article ID e48811, 2012.
227. E. Villatoro, M. Mulla, and M. Larvin, "Antibiotic therapy for prophylaxis against infection of pancreatic necrosis in acute pancreatitis, " Cochrane Database of Systematic Reviews, vol. 5, Article ID CD002941, 2010.
228. Z. Dambrauskas, A. Gulbinas, J. Pundzius, and G. Barauskas, "Meta-analysis of prophylactic parenteral antibiotic use in acute necrotizing pancreatitis, " Medicina, vol. 43, no. 4, pp. 291-300, 2007.
229. S. D. Stan, S. V. Singh, and R. E. Brand, "Chemoprevention strategies for pancreatic cancer, " Nature Reviews Gastroenterology and Hepatology, vol. 7, no. 6, pp. 347-356, 2010.
230. X.-J. Cui, Q. He, J.-M. Zhang, H.-J. Fan, Z.-F. Wen, and Y.-R. Qin, "High-dose aspirin consumption contributes to decreased risk for pancreatic cancer in a systematic review and metaanalysis, " Pancreas, vol. 43, no. 1, pp. 135-140, 2014.
231. J. Berg, H. Fellier, T. Christoph, J. Grarup, and D. Stimmeder, "The analgesic NSAID lornoxicam inhibits cyclooxygenase (COX)-1/-2, inducible nitric oxide synthase (iNOS), and the formation of interleukin (IL)-6 in vitro, " Inflammation Research, vol. 48, no. 7, pp. 369-385, 1999.
232. H. Wu, L. Liu, Q. Tan et al., "Somatostatin limits intestinal ischemia-reperfusion injury in macaques via suppression of TLR4-NF-κB cytokine pathway, " Journal of Gastrointestinal Surgery, vol. 13, no. 5, pp. 983-993, 2009.
233. H. Igarashi, M. Hijioka, L. Lee, and T. Ito, "Biotherapy of pancreatic neuroendocrine tumors using somatostatin analogs, " Journal of Hepato-Biliary-Pancreatic Sciences, 2015.
234. J. Garaude, A. Kent, N. van Rooijen, and J. M. Blander, "Simultaneous targeting of toll- and nod-like receptors induces effective tumor-specific immune responses, " Science Translational Medicine, vol. 4, no. 120, p. 120ra16, 2012.
235. S. Viaud, F. Saccheri, G. Mignot et al., "The intestinal microbiota modulates the anticancer immune effects of cyclophosphamide, " Science, vol. 342, no. 6161, pp. 971-976, 2013.
236. N. Iida, A. Dzutsev, C. A. Stewart et al., "Commensal bacteria control cancer response to therapy by modulating the tumor microenvironment, " Science, vol. 342, no. 6161, pp. 967-970, 2013.
237. C. H. F. Hansen, L. Krych, D. S. Nielsen et al., "Early life treatment with vancomycin propagates Akkermansia muciniphila and reduces diabetes incidence in the NOD mouse, " Diabetologia, vol. 55, no. 8, pp. 2285-2294, 2012.
238. S. Brugman, F. A. Klatter, J. T. J. Visser et al., "Antibiotic treatment partially protects against type 1 diabetes in the Bio- Breeding diabetes-prone rat. Is the gut flora involved in the development of type 1 diabetes?" Diabetologia, vol. 49, no. 9, pp. 2105-2108, 2006.
239. J. Hu, Y. Nomura, A. Bashir et al., "Diversified microbiota of meconium is affected by maternal diabetes status, " PLoS ONE, vol. 8, no. 11, Article ID e78257, 2013.
240. L. F. Roesch, G. L. Lorca, G. Casella et al., "Culture-independent identification of gut bacteria correlated with the onset of diabetes in a rat model, " The ISME Journal, vol. 3, no. 5, pp. 536-548, 2009.
241. M. Raderer, F. Wrba, G. Kornek et al., "Association between Helicobacter pylori infection and pancreatic cancer, " Oncology, vol. 55, no. 1, pp. 16-19, 1997.
242. R. Z. Stolzenberg-Solomon, M. J. Blaser, P. J. Limburg et al., "Helicobacter pylori seropositivity as a risk factor for pancreatic cancer, " Journal of the National Cancer Institute, vol. 93, no. 12, pp. 937-941, 2001.
243. H. A. Risch, H. Yu, L. Lu, andM. S. Kidd, "ABO blood group, helicobacter pylori seropositivity, and risk of pancreatic cancer: a case-control study, " Journal of the National Cancer Institute, vol. 102, no. 7, pp. 502-505, 2010.
244. S. Takayama, H. Takahashi, Y. Matsuo, Y. Okada, and T. Manabe, "Effects of Helicobacter pylori infection on human pancreatic cancer cell line, " Hepato-Gastroenterology, vol. 54, no. 80, pp. 2387-2391, 2007.